Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes
… approximately 1.5%, carries little risk of hypoglycemia, and is generally well-toleratedCitation28… Colesevelam HCl is not approved for type 1 diabetes or for treating diabetic ketoacidosis. …..... Read More